Studies on the goiter inhibiting action of iodolactones

M A Pisarev1, L Krawiec, G J Juvenal

  • 1División Bioquímica Nuclear, Gerencia de Radiosótopos y Radiaciones, Comisión Nacional de Energía Atómica, Buenos Aires, Argentina.

Insights

Iodolactones, compounds synthesized by the thyroid gland, effectively inhibit goiter growth and cell proliferation. These findings suggest potential therapeutic applications for iodolactones in treating thyroid conditions.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • The thyroid gland produces 6-delta-iodolactone, a compound known to inhibit goiter growth and cell proliferation.
  • Further characterization of iodolactones is needed to explore their therapeutic potential.

Purpose of the Study:

  • To further characterize the goiter-inhibiting effects of 6-delta-iodolactone and its synthetic derivative, 14-iodo-omega-lactone.
  • To investigate the therapeutic potential of iodolactones.

Main Methods:

  • Prevention assay: Rats were co-administered a goitrogen (methylmercaptoimidazole) with either 6-delta-iodolactone or 14-iodo-omega-lactone via intraperitoneal (i.p.) or oral (p.o.) routes.
  • Involution assay: Goiter was induced in rats, followed by injection of iodolactones.
  • Serum parameters (T3, T4, cholesterol, protein, urea, acetylcholinesterase) were analyzed after acute iodolactone administration.

Main Results:

  • Both iodolactones significantly decreased thyroid weight in the prevention assay, with i.p. administration being more effective than p.o.
  • A dose-response relationship was observed, with a minimal effective i.p. dose of 3 micrograms/day.
  • Significant, dose-related goiter involution was observed in the involution assay.
  • Acute iodolactone administration did not significantly alter key serum parameters.

Conclusions:

  • Iodolactones demonstrate significant efficacy in both preventing and reversing goiter in vivo.
  • The observed dose-dependent effects and lack of adverse effects on serum parameters support the potential therapeutic application of iodolactones for thyroid disorders.

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...